PBLA

Q: What is the price of Panbela Therapeutics (PBLA) today?

The current price of Panbela Therapeutics (PBLA) is $0.005000. The stock began the year trading around $0.000200 and is currently priced at $0.005000. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Panbela Therapeutics (PBLA) pay dividends?

Panbela Therapeutics (PBLA) did not pay dividends over the past year.

Panbela Therapeutics Inc.

Price

$0.005000

return (12m)

-97.50%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

PBLA price

Panbela Therapeutics

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PBLA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

400.00%

3 months

2,400.00%

1 year

-97.50%

2 years

-98.68%

5 years

-100.00%

10 years

0.00%

Fundamentals PBLA

review the fundamentals of Panbela Therapeutics shares

P/E

0.00

Sector: -3.91 Industry: -3.91

P/S (PSR)

Sector: -4.11 Industry: -4.11

P/BV

0.00

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-539.65%

Sector: -65.76% Industry: -65.76%

ROE

153.55%

Sector: -65.99% Industry: -65.99%

ROIC

-446.35%

Sector: -2,915.77% Industry: -2,915.77%

NET MARGIN

0.00%

Sector: -40.24% Industry: -40.24%

GROSS MARGIN

0.00%

Sector: 36.75% Industry: 36.75%

OPERATING MARGIN

0.00%

Sector: -39.10% Industry: -39.10%

EV/EBITDA

0.00

Sector: -4.01 Industry: -4.01

EV/EBIT

0.00

Sector: -4.09 Industry: -4.09

PRICE-TO-ASSETS

0.01

Sector: 1.44 Industry: 1.44

BVPS

-3.63

Sector: 1.85 Industry: 1.85

EPS

-5.58

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

-3.51

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

4.51

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

22.46%

Sector: - Industry: -

Fundamentals PBLA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.15	6.78	25.92%	2.29%	$550.19 B	21.83%
PFE	19.15	1.59	8.29%	6.82%	$143.47 B	11.83%
ABBV	104.57	-57.49	-54.98%	3.14%	$380.13 B	5.79%
NVO	412.02	255.86	62.10%	4.32%	$192.14 B	37.01%
MRK	31.50	6.13	19.45%	2.92%	$281.49 B	13.59%
AZN	26.08	5.72	21.93%	1.83%	$270.97 B	17.19%
GILD	16.57	6.52	39.33%	2.59%	$152.71 B	30.99%
BMY	15.13	5.47	36.19%	4.63%	$110.05 B	15.01%
ZTS	12.57	10.27	81.75%	2.62%	$33.22 B	27.79%
REGN	14.34	2.02	14.08%	0.60%	$63.43 B	29.65%
HALO	23.19	36.83	158.82%	0.00%	$8.09 B	23.13%
AMGN	23.37	19.84	84.87%	2.90%	$182.30 B	20.96%
MCK	19.23	-109.80	-570.98%	0.42%	$91.58 B	1.18%
VRTX	26.44	5.92	22.41%	0.00%	$114.71 B	35.51%
HRMY	13.25	2.12	16.00%	0.00%	$1.93 B	16.20%
CAH	33.52	-19.50	-58.20%	0.92%	$52.12 B	0.62%
BIIB	21.06	1.55	7.36%	0.00%	$28.90 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PBLA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Panbela Therapeutics

Panbela Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2014

Time since IPO - 12 years

6

Employees

Panbela Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $55.50 Thousand, with shareholders equity totaling $-18.17 million.

The company employs approximately 6 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Panbela Therapeutics Inc. reported $- in revenue, generating net income of $-27.90 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PBLA.

Market cap

$55.50 Thousand

Net worth

$-18.17 million

$-18,170,000.00

Assets

$5.17 million

$5,170,000.00

Total Shares Outstanding

5.00 million

5,000,000

Average Daily Trading Volume

$1.31 Thousand

$1,309.12

Sector

Health Care

Industry

Biotechnology

PBLA

PBLA revenue and profits

Financial Results PBLA

DRAG THE FRAME TO SEE MORE DATA

PBLA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$744.85 3,71% (12M)

P/E

19.23

0.42%

ROE

-570.98%

P/BV

-109.80

CAH - Cardinal Health

$222.74 37,69% (12M)

P/E

33.52

0.92%

ROE

-58.20%

P/BV

-19.50

JNJ - Johnson & Johnson

$231.29 56,68% (12M)

P/E

26.15

2.29%

ROE

25.92%

P/BV

6.78

MRK - Merck & Co.

$115.48 50,32% (12M)

P/E

31.50

2.92%

ROE

19.45%

P/BV

6.13

AZN - AstraZeneca

$176.35 27,19% (12M)

P/E

26.08

1.83%

ROE

21.93%

P/BV

5.72

ABBV - AbbVie

$230.01 30,27% (12M)

P/E

104.57

3.14%

ROE

-54.98%

P/BV

-57.49

PFE - Pfizer

$25.08 11,69% (12M)

P/E

19.15

6.82%

ROE

8.29%

P/BV

1.59

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$744.85 3,71% (12 M)

P/L

19.23

0.42%

ROE

-570.98%

P/VP

-109.80

CAH - Cardinal Health

$222.74 37,69% (12 M)

P/L

33.52

0.92%

ROE

-58.20%

P/VP

-19.50

JNJ - Johnson & Johnson

$231.29 56,68% (12 M)

P/L

26.15

2.29%

ROE

25.92%

P/VP

6.78

MRK - Merck & Co.

$115.48 50,32% (12 M)

P/L

31.50

2.92%

ROE

19.45%

P/VP

6.13

AZN - AstraZeneca

$176.35 27,19% (12 M)

P/L

26.08

1.83%

ROE

21.93%

P/VP

5.72

ABBV - AbbVie

$230.01 30,27% (12 M)

P/L

104.57

3.14%

ROE

-54.98%

P/VP

-57.49

PFE - Pfizer

$25.08 11,69% (12 M)

P/L

19.15

6.82%

ROE

8.29%

P/VP

1.59

Frequently Asked Questions

What is the price of Panbela Therapeutics (PBLA) today?

The current price of Panbela Therapeutics (PBLA) is $0.005000. The stock began the year trading around $0.000200 and is currently priced at $0.005000. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Panbela Therapeutics (PBLA) pay dividends?

Panbela Therapeutics (PBLA) did not pay dividends over the past year.

Is Panbela Therapeutics (PBLA) a good investment?

Panbela Therapeutics (PBLA) is currently trading at $0.005000 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -97.50%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Panbela Therapeutics (PBLA) stock?

You can buy Panbela Therapeutics (PBLA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PBLA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Panbela Therapeutics (PBLA) yield today?

Over the past month, Panbela Therapeutics (PBLA) has returned 400.00% — -97.50% over the past year, and -100.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Panbela Therapeutics (PBLA) today at the current price of $0.005000 your total investment would be $0.50.

Based on historical performance, the investment would have grown to approximately:

$0.01 after 1 year
$0.00 after 5 years
$0.50 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PBLA

Panbela Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PBLA

review the fundamentals of Panbela Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Panbela Therapeutics

Panbela Therapeutics Inc.

United States

15 years

2014

6

PROFIT X PRICE PBLA

Financial Results PBLA

PBLA cash flow

Asset, Revenue and Profit Growth - PBLA

PBLA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions